Uptake of DNA by cancer cells without a transfection reagent by unknown
Kong et al. Biol Res  (2017) 50:2 
DOI 10.1186/s40659-017-0107-x
RESEARCH ARTICLE
Uptake of DNA by cancer cells without  
a transfection reagent
Yanping Kong1*, Xianbo Zhang2, Yongliang Zhao3, Yanfang Xue4 and Ye Zhang5
Abstract 
Background: Cancer cells exhibit elevated levels of glucose uptake and may obtain pre-formed, diet-derived fatty 
acids from the bloodstream to boost their rapid growth; they may also use nucleic acid from their microenvironment. 
The study of processing nucleic acid by cancer cells will help improve the understanding of the metabolism of cancer. 
DNA is commonly packaged into a viral or lipid particle to be transferred into cells; this process is called transfection 
in laboratory. Cancer cells are known for having gene mutations and the evolving ability of endocytosis. Their uptake 
of DNAs might be different from normal cells; they may take in DNAs directly from the environment. In this report, we 
studied the uptake of DNAs in cancer cells without a transfection reagent.
Methods: A group of DNA fragments were prepared with PCR and labeled with isotope phosphorous-32 to test 
their uptake by Huh 7 (liver cancer) and THLE3 (normal liver cells) after incubation overnight by counting radioactiv-
ity of the cells’ genomic DNA. Multiple cell lines including breast cancer and lung cancer were tested with the same 
method. DNA molecules were also labeled with fluorescence to test the location in the cells using a kit of “label it 
fluorescence in situ hybridization (FISH)” from Mirus (USA).
Results: The data demonstrated that hepatocellular carcinoma cells possess the ability to take in large DNA frag-
ments directly without a transfection reagent whereas normal liver cells cannot. Huh7 and MDA-MB231 cells dis-
played a significantly higher Rhodamine density in the cytoplasmic phagosomes and this suggests that the mecha-
nism of uptake of large DNA by cancer cells is likely endocytosis. The efficacy of uptake is related to the DNA’s size. 
Some cell lines of lung cancer and breast cancer also showed similar uptake of DNA.
Conclusions: In the present study, we have revealed the evidence that some cancer cells, but not nontumorigenic 
cells, can take DNA fragments directly from the environment without the aid of the transfecting reagent.
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Background
Cancer cells have been found to contain many gene muta-
tions; they are malfunctioned in metabolism but they 
grow rapidly; their processing of nutrients and metabo-
lism might be significantly different from normal cells. 
Tumor cells exhibit elevated levels of glucose uptake, 
a phenomenon that has been capitalized upon for the 
prognostic and diagnostic imaging of a wide range of 
cancers using radio-labeled glucose analogs [1]. In addi-
tion to synthesis, cancer cells may obtain pre-formed, 
diet-derived fatty acids by uptake from the bloodstream 
through lipoprotein lipase and fatty acid translocase, and 
this can fuel their growth [2]. Whether nucleic acid like 
DNA can be taken in by cancer cells from their microen-
vironment directly is unknown. DNA molecules are big 
in general; they may not enter normal cells freely. DNAs 
are normally packaged into viral or a lipid particle to be 
transferred into cells; this process is called transfection in 
laboratory. A reagent like FuGENE is commonly used for 
the purpose. Although our previous work demonstrated 
that packaged DNA fragments with lengths of 20–40 kb 
can recombine together by creating overlapping ends on 
HSV-1 DNA fragments in E Coli [3], whether living cells 
can take DNA fragments directly without a transfection 
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reagent under a specific circumstance such as a cancerous 
condition is not clear. There are some previous reports 
suggesting direct uptake of large DNA by cells. When 
32P-labeled liver chromatin was injected intravenously 
into a rat model with partial hepatectomy, radioactivity 
in the liver cells was found to be five times higher with 
32P labeled chromatin than with inorganic 32P at 3 h post 
injection, implying that either whole chromatin or por-
tions can be incorporated into nuclei of liver cells more 
rapidly than inorganic phosphate [4]. After naked vector 
DNA carrying the beta-glycosidase gene was injected into 
mouse muscles, the gene expression observed in muscle 
cells suggested that the cells may take in DNAs directly 
[5]. Malignant cells have unique metabolic features with 
completely different gene profiles compared with normal 
cells. They could acquire the ability to take in DNA frag-
ments from the environment and use them for their fast 
growing needs. Here we provide our evaluation on the 
uptake of DNA in some malignant cells.
Methods
Cell lines
The THLE3 cells ordered from ATCC were SV40-large 
T immortalized human liver cells, which are nontumo-
rigenic and AFP expression negative, and were cultured 
in BEBM medium (Lonza/Clonetics) supplemented with 
various growth factors. Liver cancer cell lines Huh7 and 
Hep3B (from ATCC) with a higher level of AFP expres-
sion were cultured in 1640 medium supplemented 
with 10% FBS. All other cell lines in the study were also 
from ATCC and cultured with the company’s protocols: 
HMEC (normal human mammary epithelial cells), NHBE 
(human bronchial epithelial cell), NMBC (nuclear matrix 
breast cancer), BEP2D (immortalized human bronchial 
epithelial cell), HM-hT (telomerase-immortalized human 
mammary epithelial cells), SW837 (adenocarcinoma, rec-
tum), MB436 (adenocarcinoma, breast), MDA-MB231 
(adenocarcinoma, breast epithelial), A549 (lung cancer), 
H1299 (lung cancer, epithelial), H460 (large cell lung 
cancer).
DNAs and their labeling with α‑32P‑dCTP
The AFP DNA fragments with different lengths ranging 
from 57 to 1620 bp were prepared by PCR amplification 
in the presence of α-32P-dCTP (PerkinElmer) using AFP 
cDNA as template. The reaction was as follows: 10× LA 
buffer 5  µl; 10  mmol/l dNTP (dATP +  dTTP +  dGTP) 
1  µl; 0.1  mmol/l dCTP 1  µl; sense primer 2  µl; anti-
sense primer 2  µl; AFP template DNA (pCMV-sport6-
AFP, 50 ng/µl) 1 µl; α-32P-dCTP 5 µl (10 µci/µl); LA Taq 
DNA polymerase 1  µl; H2O 32  µl. The PCR protocol: 
94  °C 3 min; 94  °C 30  s, 55  °C 30  s, 72  °C 3 min for 40 
cycles. The PCR products were then purified using G50 
columns (Amersham) according to manufacturer’s proto-
col, and named as ISONA (isotope labeled nucleic acids). 
ISONA150 refers to a 150 base pair fragment; the primers 
for making this fragment are ACTCCAGTAAACCCTGG 
TGTTG and CTGAGCTTGGCACAGATCCTTATG. 
Genomic DNA isolated from Huh7 cells was 32P-labeled 
in the presence of α-32P-dCTP using a random labeling 
kit (New England Biolab following its protocol). The 
labeled products were purified by using G50 columns.
Incubation of cells with α‑32P‑dCTP ‑labeled DNA 
fragments
The cells was seeded in 24 well plates with a cell density 
of 6 × 104 cells per well. Twenty-four hours later, α-32P-
dCTP -labeled DNA fragments were added into each well 
and the cells were kept in the incubator for different time 
periods as designed. Genomic DNAs were then isolated 
with DNAzole reagents, and radioactivity of genomic 
DNAs were quantified by a scintillation counter and 
visualized by dot-blotting after being exposed to Kodak 
films. The result of radioactivity was counted as counts 
per minute (CPM).
Fluorescence labeling DNA to test its uptake in cancer cells 
and related normal cells
A kit of “label it fluorescence in  situ hybridization 
(FISH)” from Mirus (USA) was used in this study fol-
lowing the company’s protocol. AFP cDNA (1.8 kb) was 
PCR-amplified, purified by phenol–chloroform extrac-
tion and adjusted to the concentration of 1 µg/µl. A 5 µg 
DNA template was used for fluorescein labeling at 37 °C 
for 1 h with Rhodamine, and the labeled probe was puri-
fied using a G50 column. The cells were incubated with 
the labeled probe at 37 °C for 16 h, then washed with PBS 
and fixed in 4% paraformaldehyde. After co-stained with 
DAPI, cell images were captured by a Leica confocal laser 
scanning microscope TCS SP (Leica). The fluorescence 
density of Rhodamine in cytoplasmic phagosomes was 
quantified by Image J software (http://imagej.net/Wel-
come). At least 100 cells were quantified for each cell line. 
The data in the bars represent mean ± SD from two inde-
pendent experiments. Student’s t test was used for statis-
tical analysis. p < 0.01 (**) was considered as statistically 
significant.
Results
DNA fragments were taken by HCC cells but not normal 
liver cells without transfection reagent
To prove the hypothesis that cancer cells may have the 
ability to take DNA fragments directly without packaging 
with transfection reagent, DNA fragments with differ-
ent lengths were tested in THLE3 and Huh7 cells with-
out adding the transfection reagent. As shown in Fig. 1a, 
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the quality of a DNA fragment prepared with PCR was 
excellent. The radioactivity of genomic DNA isolated 
from AFP-positive Huh7 cells is significantly higher 
than that from AFP-negative noncancerous THLE3 
cells. This data provided strong evidence that the naked 
DNA fragments without any packaging can be taken up 
by Huh7 cells (cancer), but not by THLE3 cells (normal). 
The 32P-labeled DNA had been integrated into genomic 
DNAs of Huh7 cells, and all sized DNA fragments in this 
experiment can enter into the cells with high efficiency 
even though the efficiency tends to be decreased along an 
increased length (Fig. 1b).
Uptake efficiency of DNA fragment with or without a 
transfection agent
ISONA150 was tested in two kinds of liver cancer cell 
lines—Huh7 and Hep3b with or without FuGENE 
(Fig.  2). FuGENE is commonly used in labs to facilitate 
a cell’s uptake of DNAs. In Huh7, cells with more DNA 
added have higher radioactivity and there was no sig-
nificant difference with a different concentration of 
FuGENE. The data here suggested that uptake of ISONA 
is independent of FuGENE but related to the amount of 
DNA. In Hep3b cells, the uptake is much lower com-
pared with Huh7.
Uptake of ISONA150 compared with genomic DNAs; DNA 
size and uptake; and uptake of ISONA in different cell lines
Uptake of ISONA150 and 32P-dCTP-labeled genomic 
DNA from Huh-7 cells by the random labeling kit was 
tested in Huh7 cells at different times of incubation. The 
efficiency of uptake of both DNA fragments as shown in 
Fig.  3a, was comparably similar, but it is more efficient 
with the genomic DNA. DNA fragments with designated 
sizes were absorbed into Huh7 cells much more effi-
ciently than a single nucleotide was and this was related 
to DNA size (Fig. 3b). We further tested the uptake effi-
ciency of ISONA by different histological types of human 
cancer cells with undetectable levels of AFP expression. 
Intriguingly, some breast cancer and lung cancer cell 
lines displayed a very high level of uptake; whereas, non-
tumorigenic cells like BEP2D showed a very low level of 
uptake (Fig. 3c). The test results suggest that only cancer 
cells evolved the ability to directly take up large DNA 
fragments. Moreover, selectivity for the types of DNA in 
the uptake by different cancer cells was not observed.
Fluorescence labelled DNA uptake
Uptake of Rhodamine fluorescence labeled DNA probe 
was further tested in the normal and cancer cells, and 
analyzed under confocal microscope. As shown in Fig. 4, 
Fig. 1 Uptake of DNA fragments with different size by HCC cells versus normal liver cells. a Different size of AFP cDNA fragments were prepared 
with PCR (57, 150, 310, 570 and 1620 bp). b After incubation with the cells overnight, radioactivity was visualized by dot blot (the top picture); tripli-
cate wells were used to test each DNA fragment in the two cell lines. The radioactivity was also quantified by scintillation counter (the lower picture). 
The uptake is very strong in HCC cells but is minimal in normal liver cells. There is at least a tenfold difference
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after overnight incubation with fluorescence-labeled 
DNA probe, a significantly higher level of Rhodamine flu-
orescence was observed in the cytoplasm of cancer cells 
(Huh7 and MDA-MB231), but not in their corresponding 
normal control cells (THEL3 and HMEC). In addition, 
the Rhodamine fluorescence was mainly localized in the 
phagosomes of cytoplasmic compartment. Intriguingly, 
some of the phagosomes can be counterstained by DAPI, 
demonstrating that rhodamine-labeled DNA has truly 
entered into the cells by phagocytosis.
Discussion
DNA transfer into cells with a transfection reagent has 
been well studied for the purpose of gene therapy [6, 7]. 
How cancer cells process the uptake of nucleic acids in 
a biological environment is not clear. Investigation of 
nucleic acid uptake by cancer cells will help improve the 
understanding of the metabolism of cancer. This study 
provides evidence that cancer cells including HCC but 
not normal liver cells can take large naked DNA frag-
ments (compared with oligonucleotides which are nor-
mally less than 20 base pairs and considered small) 
without the aid of either viral proteins or liposome/
FuGENE reagents. AFP DNA was chosen in this study 
because it is unique in liver cancer and was considered as 
highly needed by the cells. Huh7 cells that express a high 
level of endogenous AFP gene revealed a high capacity 
of uptake of AFP DNA fragment. This leads to a possi-
ble explanation that the uptake of DNA by cancer cells 
might be need-based. However, lung cancer and breast 
cancer cells can also take AFP DNA the same way; they 
might digest the DNAs first and then have those nucleo-
tides used. The detailed mechanism of DNA fragments 
transportation into cells is still not clear. To determine 
whether endocytosis may serve as the possible mecha-
nism for cellular DNA transportation, a fluorescence 
study was carried out to test the phagocytosis in HCC 
and breast cancer cells in comparison with their cor-
responding normal cells following the recommended 
protocol [8]. Since FITC (Fluorescein Isothiocyanate) 
fluorescence dye is pH-sensitive and can be quenched 
within phagosomes with acidic condition, we used rho-
damine dye exhibiting much less quenching over a wide 
range of pH (from pH 4 to 9) to label the AFP cDNA 
(1.8  kb) using label IT Nucleic Acid labeling kit. The 
results showed that Huh7 and MDA-MB231 cells dis-
played a significantly higher Rhodamine density in the 
cytoplasmic phagosomes. Intriguingly, some of the 
phagosomes can be counterstained by DAPI, demon-
strating that rhodamine-labeled DNA has truly entered 
into the cells by phagocytosis. Glucose and amino acids 
are transported through the cell membrane by specific 
transporters located on the cell membrane. At least four 
glucose transporters have been identified so far through 
the studies of glucose metabolism in diabetes [9, 10]. 
The small DNA fragment may go through a similar path-
way. Mellman and Yarden [11] wrote a review in 2013 
describing endocytosis of cancer cells, in which it stated 
that cancer cells might be able to undergo endocytosis to 
match their high proliferation pace. The endocytosis is 
possibly related to gene mutations like P-53 [12]. Some 
well-known proteins from cancer were found respon-
sible for the processing of endocytosis and related to 
the cancers’ aggressiveness [13]. Malignant cells with 
a high proliferation rate might evolve a specific mecha-
nism for utilizing the extracellular DNA fragments to 
support their high rate of DNA replication. Our study 
using fluorescent-labeled DNA fragment revealed that 
the DNAs were taken up by phagocytosis. This suggests 
that the uptake of larger DNA by cancer cells is likely 
Fig. 2 Uptake of ISONA by Huh7 and Hep3B cells with or without 
FuGENE The radioactivity was visualized by either dot blot (a) or 
quantified by scintillation counter (b). ISONA150 was added to Hep3B 
(l, 2, 3) and Huh7 [4–6]. Lines 1 and 4: 6 µl of 2 µg ISONA150 without 
FuGENE; lines 2 and 5: 6 µl of 2 µg ISONA150 + 3 µl FuGENE; lines 3 
and 6: 6 µl of 1 µg ISONA150 + 4 µl FuGENE. In the third well of line 5: 
1 µl of 0.33 µg ISONA + 4 µl FuGENE. Line 4 of Huh 7 cells had strong 
uptake even without FuGene added. The well of line 5 with less DNA 
probe showed much lower uptake compared with others of 4, 5 and 6
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through endocytosis. The fact that the uptake of DNA is 
not mainly dependent on the transfection agent FuGENE 
also suggests that it is not utilizing passive transporting. 
Large DNA was absorbed into Huh7 cells much more 
efficiently than a single nucleotide and was size sensitive 
as shown in Fig. 3b. All the DNA fragments used in the 
test were from AFP genomic DNA; the result might be 
secondary to the efficacy of endocytosis which may be 
related to the molecule’s size. The study of different cell 
lines also revealed that those aggressive cancers have the 
ability to take large DNA, which supports the hypothesis 
that endocytosis is related to the aggressiveness of can-
cer. Meanwhile, the uptake study showed no uptake of 
the DNA fragments by normal liver cells and breast cells. 
This reveals that endocytosis of DNA is unlikely to exist 
in those cells. The difference might be used for cancer 
treatment. The uptake happens as early as 10  min after 
DNA is added to the cell culture; it demonstrates that the 
cancer cell can take those DNAs very efficiently. As for 
some cancer cells like Hep3B that did not show the same 
ability to take those DNA fragments as Huh7, further 
investigation is required. As mentioned above, the endo-
cytosis of cancer cells are related to some genes muta-
tions especially p-53. Hep3B has no expression of p-53, 
but Huh7 has mutated p-53 [14]; this might cause the dif-
ference in the ability of cellular endocytosis. The detailed 
mechanism of exogenous DNA transporting into cancer 
cells worth further evaluation.
Conclusions
In conclusion, our study suggests that cancer cells may 
take in large DNA directly from the environment and 
that is possibly through endocytosis which does not hap-
pen in normal cells.
Fig. 3 Uptake of AFP DNA or genomic DNA by HCC cells, and uptake of ISONA by different cell liners. a Both ISONA150 and genomic DNAs can 
be taken up efficiently by Huh7 but not by THLE-3 cells. The uptake was significant as early as 10 min after DNA was added. b Uptake of DNA frag-
ments was compared with single nucleotide, it is size dependent and unlikely to be taken up when the size is over 6.7 kb. c ISONA compounds 
were incubated with different cell lines overnight, uptake was significant in breast cancer, lung cancer and liver cancer cells. The uptake is minimal 
in noncancerous cells
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